Oncostellae is a biotechn startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.
Total raised: $1M
Founded date: 2013
Investors 1
Date | Name | Website |
- | Fitalent | fitalent.e... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
12.02.2016 | Seed | $1M | - | finsmes.co... |
Mentions in press and media 6
Date | Title | Description | Source |
05.07.2023 | Bio & Tech Smart Capital invierte medio millón de euros ... | 05/07/2023 Nota de prensa BIO & TECH SMART CAPITAL INVIERTE MEDIO MILLÓN DE EUROS EN LA GALLEG... | webcapital... |
23.11.2022 | Oncostellae abre una ronda de €3,3M en la que participarán I... | 23/11/2022 Nota de prensa ONCOSTELLAE ABRE UNA RONDA DE €3,3M EN LA QUE PARTICIPARÁN INVEREADY, XE... | webcapital... |
06.07.2022 | Oncostellae cierra una ronda en la que participan Xesgalicia... | 04/07/2022 Nota de prensa ONCOSTELLAE CIERRA UNA RONDA EN LA QUE PARTICIPAN XESGALICIA, INVEREADY,... | webcapital... |
12.02.2016 | Oncostellae Raises $1M in Seed Funding | Oncostellae, a San Cibrao das Viñas, Spain-based biotech company that discovers and develops small m... | finsmes.co... |
12.02.2016 | Daily funding roundup - February 12, 2016 | payleven received $10M; RKSV raised $4M; Jisto closed a $2.45M Seed funding LetterOne, a Luxembourg... | vator.tv/n... |
- | Oncostellae | “Oncostellae is a biotechn startup developing small-molecule drugs with innovative scaffolds (NCEs) ... | fastfounde... |